Awareness of risk when prescribing and taking combined hormonal contraceptives (CHCs): a qualitative study with women and health professionals in three European countries

Objectives To explore the experiences of women and health professionals when communicating about combined hormonal contraceptives (CHCs), with a focus on venous thromboembolism (VTE). We also focused on information sources consulted by women for their decision-making process regarding contraceptives...

Full description

Saved in:
Bibliographic Details
Main Authors: Irene Petersen, Vera Ehrenstein, Fiona A Stevenson, Paula Cristina Gomes Alves, Iveta Nagyova, Zuzana Katreniaková
Format: Article
Language:English
Published: BMJ Publishing Group 2025-03-01
Series:BMJ Open
Online Access:https://bmjopen.bmj.com/content/15/3/e084735.full
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849705628573892608
author Irene Petersen
Vera Ehrenstein
Fiona A Stevenson
Paula Cristina Gomes Alves
Iveta Nagyova
Zuzana Katreniaková
author_facet Irene Petersen
Vera Ehrenstein
Fiona A Stevenson
Paula Cristina Gomes Alves
Iveta Nagyova
Zuzana Katreniaková
author_sort Irene Petersen
collection DOAJ
description Objectives To explore the experiences of women and health professionals when communicating about combined hormonal contraceptives (CHCs), with a focus on venous thromboembolism (VTE). We also focused on information sources consulted by women for their decision-making process regarding contraceptives.Design Qualitative semistructured face-to-face interviews were conducted with 24 women and 16 health professionals. The study followed a phenomenological approach, and data were synthesised using the framework analysis method.Setting Community health centres across three countries in the UK, Denmark, and Slovakia.Participants Adult (aged 18+) women using CHC and health professionals eligible to prescribe CHC in their respective countries.Results Women tended to be positive about CHC’s safety and seek information about CHC through their health professionals, family and friends. They would like to receive further information from health professionals, particularly when it comes to risks of CHC and alternative methods of contraception. Health professionals reported using a variety of methods to communicate about CHC and generally report giving advice based on national and local guidelines. In line with women’s perspectives, they reported time constraints and lack of resources as barriers to communication about CHC. Health professionals in our sample believed there is a lack of standardisation in the information offered and guidelines used to prescribe CHC, with little contact with international regulators such as the European Medicines Agency.Conclusions It is necessary to improve the conditions under which contraceptive counselling is provided, as well as supporting health professionals in this task. Exploring the lived experiences of women and health professionals about how they discuss contraception choices can shed light on the best approaches to improve reproductive health consultations.
format Article
id doaj-art-b4516e782da24cd3a54c10a7fde513c9
institution DOAJ
issn 2044-6055
language English
publishDate 2025-03-01
publisher BMJ Publishing Group
record_format Article
series BMJ Open
spelling doaj-art-b4516e782da24cd3a54c10a7fde513c92025-08-20T03:16:25ZengBMJ Publishing GroupBMJ Open2044-60552025-03-0115310.1136/bmjopen-2024-084735Awareness of risk when prescribing and taking combined hormonal contraceptives (CHCs): a qualitative study with women and health professionals in three European countriesIrene Petersen0Vera Ehrenstein1Fiona A Stevenson2Paula Cristina Gomes Alves3Iveta Nagyova4Zuzana Katreniaková52 Research Department of Primary Care and Population Health, University College London, London, UK3 Department of Clinical Epidemiology, Aarhus University & Aarhus University Hospital, Aarhus, Denmark2 Research Department of Primary Care and Population Health, University College London, London, UK1 Institute for Lifecourse Development, Centre for Mental Health, University of Greenwich, London, UK4 Department of Social and Behavioural Medicine, Faculty of Medicine, Pavol Jozef Safarik University, Kosice, Slovakia4 Department of Social and Behavioural Medicine, Faculty of Medicine, Pavol Jozef Safarik University, Kosice, SlovakiaObjectives To explore the experiences of women and health professionals when communicating about combined hormonal contraceptives (CHCs), with a focus on venous thromboembolism (VTE). We also focused on information sources consulted by women for their decision-making process regarding contraceptives.Design Qualitative semistructured face-to-face interviews were conducted with 24 women and 16 health professionals. The study followed a phenomenological approach, and data were synthesised using the framework analysis method.Setting Community health centres across three countries in the UK, Denmark, and Slovakia.Participants Adult (aged 18+) women using CHC and health professionals eligible to prescribe CHC in their respective countries.Results Women tended to be positive about CHC’s safety and seek information about CHC through their health professionals, family and friends. They would like to receive further information from health professionals, particularly when it comes to risks of CHC and alternative methods of contraception. Health professionals reported using a variety of methods to communicate about CHC and generally report giving advice based on national and local guidelines. In line with women’s perspectives, they reported time constraints and lack of resources as barriers to communication about CHC. Health professionals in our sample believed there is a lack of standardisation in the information offered and guidelines used to prescribe CHC, with little contact with international regulators such as the European Medicines Agency.Conclusions It is necessary to improve the conditions under which contraceptive counselling is provided, as well as supporting health professionals in this task. Exploring the lived experiences of women and health professionals about how they discuss contraception choices can shed light on the best approaches to improve reproductive health consultations.https://bmjopen.bmj.com/content/15/3/e084735.full
spellingShingle Irene Petersen
Vera Ehrenstein
Fiona A Stevenson
Paula Cristina Gomes Alves
Iveta Nagyova
Zuzana Katreniaková
Awareness of risk when prescribing and taking combined hormonal contraceptives (CHCs): a qualitative study with women and health professionals in three European countries
BMJ Open
title Awareness of risk when prescribing and taking combined hormonal contraceptives (CHCs): a qualitative study with women and health professionals in three European countries
title_full Awareness of risk when prescribing and taking combined hormonal contraceptives (CHCs): a qualitative study with women and health professionals in three European countries
title_fullStr Awareness of risk when prescribing and taking combined hormonal contraceptives (CHCs): a qualitative study with women and health professionals in three European countries
title_full_unstemmed Awareness of risk when prescribing and taking combined hormonal contraceptives (CHCs): a qualitative study with women and health professionals in three European countries
title_short Awareness of risk when prescribing and taking combined hormonal contraceptives (CHCs): a qualitative study with women and health professionals in three European countries
title_sort awareness of risk when prescribing and taking combined hormonal contraceptives chcs a qualitative study with women and health professionals in three european countries
url https://bmjopen.bmj.com/content/15/3/e084735.full
work_keys_str_mv AT irenepetersen awarenessofriskwhenprescribingandtakingcombinedhormonalcontraceptiveschcsaqualitativestudywithwomenandhealthprofessionalsinthreeeuropeancountries
AT veraehrenstein awarenessofriskwhenprescribingandtakingcombinedhormonalcontraceptiveschcsaqualitativestudywithwomenandhealthprofessionalsinthreeeuropeancountries
AT fionaastevenson awarenessofriskwhenprescribingandtakingcombinedhormonalcontraceptiveschcsaqualitativestudywithwomenandhealthprofessionalsinthreeeuropeancountries
AT paulacristinagomesalves awarenessofriskwhenprescribingandtakingcombinedhormonalcontraceptiveschcsaqualitativestudywithwomenandhealthprofessionalsinthreeeuropeancountries
AT ivetanagyova awarenessofriskwhenprescribingandtakingcombinedhormonalcontraceptiveschcsaqualitativestudywithwomenandhealthprofessionalsinthreeeuropeancountries
AT zuzanakatreniakova awarenessofriskwhenprescribingandtakingcombinedhormonalcontraceptiveschcsaqualitativestudywithwomenandhealthprofessionalsinthreeeuropeancountries